Primary tumor resection improves the survival of younger patients with metastatic breast cancer

Oncology Reports

Volumn 21, Issue 3, 2009, Pages 827-832

  Shien, Tadahiko ^a   Kinoshita, Takayuki ^a   Shimizu, Chikako ^b   Hojo, Takashi ^a   Taira, Naruto ^a   Doihara, Hiroyoshi ^a   Akashi Tanaka, Sadako ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Breast; Stage IV; Surgery

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TRASTUZUMAB;

ADULT; AGED; BONE METASTASIS; BREAST CANCER; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOFT TISSUE METASTASIS; SURVIVAL TIME; VISCERAL METASTASIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING;

EID: 64849098639     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000291     Document Type: Review

References (19)

1. National Cancer Institute: The treatment of primary breast cancer: Management of local disease. NIH Concensus Development Conference Summary 2: 1-3, 1994.
2. National Institutes of Health Consensus Development Panel: Consensus statement: treatment of early stage breast cancer. J Natl Cancer Inst Monogr 11: 1-5, 1992.
3. Rapiti E, Verkooijen HM, Vlastos G, et al: Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24: 2743-2749, 2006.
4. Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C and Margenthaler JA: Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER Data. Ann Surg Oncol 14: 2187-2194, 2007.
5. Babiera GV, Rao R, Feng L, et al: Effect of primary tumor extirpation in breast cancer patients who present with Stage IV disease and an intact primary tumor. Ann Surg Oncol 13: 776-782, 2005.
6. Khan SA, Stewart AK and Morrow M: Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 132: 620-627, 2002.
7. Hortobagyi GN: Treatment of breast cancer. N Engl J Med 339: 974-984, 1998.
8. Buzdar AU, Ibrahim NK, Francis D, et al: Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 23: 3676-3685, 2005.
9. Bear HD, Anderson S, Smith RE, et al: Sequential preoperatrive or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24: 1-9, 2006.
10. Turner L, Swindell R, Bell WGT, Hartley RC, Tasker JH, Wilson WW, et al: Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl 63: 239-243, 1981.
11. Fisher B, Jeong J-H, Anderson S, Bryant J, Fisher ER and Wolmark N: Twenty-five-year follow up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347: 567-575, 2002.
12. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227-1232, 2002.
13. Dalberg K, Liedberg A, Johansson U and Rutqvist LE: Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence. Eur J Surg Oncol 29: 143-154, 2003.
14. Yamamoto N, Katsumata N, Watanabe T, Omuro Y, Ando M, Narabayashi M and Adachi I: Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment. Jpn J Clin Oncol 28: 368-373, 1998.
15. Rosen SA, Buell JF, Yoshida A, et al: Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135: 530-534, 2000.
16. Martin R, Paty P, Fong Y, et al: Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197: 233-241, 2003.
17. Flanigan RC, Salmon SE, Blumenstein BA, et al: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal cell cancer. N Engl J Med 345: 1655-1659, 2001.
18. Chi DS, Eisenhauer EL, Lang J, et al: What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103: 559-564, 2006.
19. Norton L and Massague J: Is cancer a disease of self-seeding? Nat Med 12: 875-878, 2006.